13th July 2026

Mrs Carter, a 55-year-old woman with type 2 diabetes, has been reading about different treatment options on the internet, and is considering starting a pioglitazone for glycaemic control.

Mrs Carter, a 55-year-old woman with type 2 diabetes, has been reading about different treatment options on the internet, and is considering starting a pioglitazone for glycaemic control. She has a history of severe liver cirrhosis. How should the potential risk of hepatotoxicity associated with pioglitazones be managed in this patient?

Select the SINGLE most appropriate option from the list below. Select ONE option only.